215 related articles for article (PubMed ID: 36997534)
1. MYC reshapes CTCF-mediated chromatin architecture in prostate cancer.
Wei Z; Wang S; Xu Y; Wang W; Soares F; Ahmed M; Su P; Wang T; Orouji E; Xu X; Zeng Y; Chen S; Liu X; Jia T; Liu Z; Du L; Wang Y; Chen S; Wang C; He HH; Guo H
Nat Commun; 2023 Mar; 14(1):1787. PubMed ID: 36997534
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops.
Guo Y; Perez AA; Hazelett DJ; Coetzee GA; Rhie SK; Farnham PJ
Genome Biol; 2018 Oct; 19(1):160. PubMed ID: 30296942
[TBL] [Abstract][Full Text] [Related]
3. Acute depletion of CTCF directly affects MYC regulation through loss of enhancer-promoter looping.
Hyle J; Zhang Y; Wright S; Xu B; Shao Y; Easton J; Tian L; Feng R; Xu P; Li C
Nucleic Acids Res; 2019 Jul; 47(13):6699-6713. PubMed ID: 31127282
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional genome architectural CCCTC-binding factor makes choice in duplicated enhancers at Pcdhα locus.
Wu Y; Jia Z; Ge X; Wu Q
Sci China Life Sci; 2020 Jun; 63(6):835-844. PubMed ID: 32249388
[TBL] [Abstract][Full Text] [Related]
5. The LDB1 Complex Co-opts CTCF for Erythroid Lineage-Specific Long-Range Enhancer Interactions.
Lee J; Krivega I; Dale RK; Dean A
Cell Rep; 2017 Jun; 19(12):2490-2502. PubMed ID: 28636938
[TBL] [Abstract][Full Text] [Related]
6. An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis.
Li J; Huang K; Hu G; Babarinde IA; Li Y; Dong X; Chen YS; Shang L; Guo W; Wang J; Chen Z; Hutchins AP; Yang YG; Yao H
Nat Commun; 2019 Apr; 10(1):1535. PubMed ID: 30948729
[TBL] [Abstract][Full Text] [Related]
7. Local chromatin interactions contribute to expression of the fibrinogen gene cluster.
Espitia Jaimes C; Fish RJ; Neerman-Arbez M
J Thromb Haemost; 2018 Oct; 16(10):2070-2082. PubMed ID: 30039577
[TBL] [Abstract][Full Text] [Related]
8. Chromium disrupts chromatin organization and CTCF access to its cognate sites in promoters of differentially expressed genes.
VonHandorf A; Sánchez-Martín FJ; Biesiada J; Zhang H; Zhang X; Medvedovic M; Puga A
Epigenetics; 2018; 13(4):363-375. PubMed ID: 29561703
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9 offers a new tool for studying the role of chromatin architecture in disease pathogenesis.
Guo X; Dean A
Genome Biol; 2018 Nov; 19(1):185. PubMed ID: 30400943
[TBL] [Abstract][Full Text] [Related]
10. Variable Extent of Lineage-Specificity and Developmental Stage-Specificity of Cohesin and CCCTC-Binding Factor Binding Within the Immunoglobulin and T Cell Receptor Loci.
Loguercio S; Barajas-Mora EM; Shih HY; Krangel MS; Feeney AJ
Front Immunol; 2018; 9():425. PubMed ID: 29593713
[TBL] [Abstract][Full Text] [Related]
11. Acute depletion of CTCF rewires genome-wide chromatin accessibility.
Xu B; Wang H; Wright S; Hyle J; Zhang Y; Shao Y; Niu M; Fan Y; Rosikiewicz W; Djekidel MN; Peng J; Lu R; Li C
Genome Biol; 2021 Aug; 22(1):244. PubMed ID: 34429148
[TBL] [Abstract][Full Text] [Related]
12. Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains.
Khoury A; Achinger-Kawecka J; Bert SA; Smith GC; French HJ; Luu PL; Peters TJ; Du Q; Parry AJ; Valdes-Mora F; Taberlay PC; Stirzaker C; Statham AL; Clark SJ
Nat Commun; 2020 Jan; 11(1):54. PubMed ID: 31911579
[TBL] [Abstract][Full Text] [Related]
13. YY1 and CTCF orchestrate a 3D chromatin looping switch during early neural lineage commitment.
Beagan JA; Duong MT; Titus KR; Zhou L; Cao Z; Ma J; Lachanski CV; Gillis DR; Phillips-Cremins JE
Genome Res; 2017 Jul; 27(7):1139-1152. PubMed ID: 28536180
[TBL] [Abstract][Full Text] [Related]
14. Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation.
Fang C; Wang Z; Han C; Safgren SL; Helmin KA; Adelman ER; Serafin V; Basso G; Eagen KP; Gaspar-Maia A; Figueroa ME; Singer BD; Ratan A; Ntziachristos P; Zang C
Genome Biol; 2020 Sep; 21(1):247. PubMed ID: 32933554
[TBL] [Abstract][Full Text] [Related]
15. SATB1 regulates 3D genome architecture in T cells by constraining chromatin interactions surrounding CTCF-binding sites.
Wang B; Ji L; Bian Q
Cell Rep; 2023 Apr; 42(4):112323. PubMed ID: 37000624
[TBL] [Abstract][Full Text] [Related]
16. Many facades of CTCF unified by its coding for three-dimensional genome architecture.
Wu Q; Liu P; Wang L
J Genet Genomics; 2020 Aug; 47(8):407-424. PubMed ID: 33187878
[TBL] [Abstract][Full Text] [Related]
17. Distinct properties and functions of CTCF revealed by a rapidly inducible degron system.
Luan J; Xiang G; Gómez-García PA; Tome JM; Zhang Z; Vermunt MW; Zhang H; Huang A; Keller CA; Giardine BM; Zhang Y; Lan Y; Lis JT; Lakadamyali M; Hardison RC; Blobel GA
Cell Rep; 2021 Feb; 34(8):108783. PubMed ID: 33626344
[TBL] [Abstract][Full Text] [Related]
18. The effect of CTCF binding sites destruction by CRISPR/Cas9 on transcription of metallothionein gene family in liver hepatocellular carcinoma.
Gong W; Liu Y; Qu H; Liu A; Sun P; Wang X
Biochem Biophys Res Commun; 2019 Mar; 510(4):530-538. PubMed ID: 30738580
[TBL] [Abstract][Full Text] [Related]
19. The human β-globin enhancer LCR HS2 plays a role in forming a TAD by activating chromatin structure at neighboring CTCF sites.
Kim J; Kang J; Kim YW; Kim A
FASEB J; 2021 Jun; 35(6):e21669. PubMed ID: 34033138
[TBL] [Abstract][Full Text] [Related]
20. Targeted deletion of multiple CTCF-binding elements in the human C-MYC gene reveals a requirement for CTCF in C-MYC expression.
Gombert WM; Krumm A
PLoS One; 2009 Jul; 4(7):e6109. PubMed ID: 19568426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
